Evidence map›Paper›PMID 25182014›Full record

ReviewCurrent heart failure reports2014

Understanding the epidemic of heart failure: past, present, and future.

Shannon M Dunlay, Véronique L Roger

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Current heart failure reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06117722 (ESTIA), which is not on this map. Cited by 116 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed, 4 pooled it
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06117722 unknown statusnot on this mapstarted 2024, after this paper: background citation

ESTIA: TorasEmide Induced Effect on Quality of Life and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone. Multicenter, Non-interventional, Prospective, Observational Clinical Study.

TypeobservationalSponsorElpen Pharmaceutical Co. Inc.Ran2024 to 2025Enrolled210ConditionsChronic Heart FailureArmsEplerenone torasemide in chronic heart failure
3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 4 syntheses or guidelines pooled it, 228 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Vitamin DBMC cardiovascular disorders · 2017
    Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Discordance Between HJournal of clinical practice and research · 2025
    Review
  19. Article
  20. Article

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shannon M DunlayDivision of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Gonda 5, 200 First St. SW, Rochester, MN, 55905, USA, dunlay.shannon@mayo.edu.
Véronique L Roger
Mayo Clinic · US

Funding

End of Life Preferences and Healthcare Resource Use in Heart Failure PatientsK23HL116643 · NHLBI · MAYO CLINIC ROCHESTER · PI DUNLAY, SHANNON MARIE · 2013 to 2017
$739k
NHLBI NIH HHS K23 HL116643
6 · The paper itself

Abstract

Heart failure (HF) is a major public health problem affecting more than five million Americans and more than 23 million patients worldwide. The epidemiology of HF is evolving. Data suggests that the incidence of HF peaked in the mid-1990s and has since declined. Survival after HF diagnosis has improved, leading to an increase in prevalence. The case mix is also changing, as a rising proportion of patients with HF have preserved ejection fraction and multimorbidity is increasingly common. After diagnosis, HF can have a profound associated morbidity. Hospitalizations in HF remain both frequent and costly, though they may be declining as a result of preventive efforts. The need for skilled nursing facility care in HF has risen. The role of palliative medicine in the care of patients with advanced HF is evolving as we learn how to best care for this population with a large symptom burden.

Indexed as

Global HealthComorbidityDiagnosis-Related GroupsForecastingHeart FailureHumansIncidencePatient ReadmissionPrevalence

Identifiers

PMID25182014
PMCPMC4224604
OpenAlexW2021976883

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.